A key factor in Illinois’ ability to detect, monitor and control antimicrobial resistance is its public health laboratory capacity. Across the nation, rising numbers of cases of antimicrobial resistance are currently challenging the ability of state public health laboratories keep pace. Despite this, funding available to public health departments for laboratory-based antimicrobial resistance surveillance continues to decrease.
1 Dr. Fred Tenover, quoted in “The Bacteria Fight Back” Science, July 18, 2008. 2 R. Monina Klevens et al. “Invasive Methicillin-resistant Staphylococcus aureus Infections in the United States,” JAMA, October 17, 2007: 1763-1771.3 Elixhauser, A. and Steiner, C. Infections with Methicillin-Resistant Staphylococcus aureus (MRSA) in U.S. Hospitals, 1993–2005. HCUP Statistical Brief #35. July 2007. Agency for Healthcare Research and Quality.4 MRSA in Illinois: Descriptive Analysis of Hospital Discharge Data 2002-2006. Illinois Department of Public Health, 2008.5 ibid6 CDC MMWR “Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities” March 20, 2009 / Vol. 58 / No. 107 K. F. Anderson, et al.; Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae; Journal of Clinical Microbiology, August 2007, p. 2723-2725, Vol. 45, No. 88 CDC Wonder Death Certificate Data, cited in a July 28, 2008 communication to Senator Sherrod Brown
Illinois AR Fact Sheet
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America